Title (fr)

Publication

Application

Priority

TW 96129940 A 20070814

Abstract (en)

The present invention relates to a short-chain peptide anti-cancer drug and its use to maintain the stability and safety of cancer therapy. The short-chain peptide is extracted from a protein associated with mitosis and has molecular weight less than 60KDa such that the short-chain peptide cannot permeate a normal blood vessel that has a smaller porous size and will not damage normal cells but will be delivered and diffused to cancer cells by an anti-angiogenesis treatment to inhibit cancer cell growth.